Related Experiment Videos
Abstract:
Paraneoplasia has come to denote those tumor activities not caused within an organism directly by invasion, obstruction, or by the tumor burden itself. PSN research has yielded best results through the examination of those hormones produced by the tumor, esp. the pro-ACTH and its functionally active subgroups, furthermore the ADH, gonadotropins, HPL, STH, prolactine etc. Frequently very special features have been found to characterize this disease which have been published in detail. In addition to this, several differentiating PNS have been described without having been sufficiently defined, esp. those concerning the nervous system, the haematopoesia , the kidneys, the skin and the gastrointestinal system. In very rare cases there has been a mention or different characteristic syndromes that have come to be assigned to special kinds of tumors.
Insights
Paraneoplastic syndromes (PSN) involve tumor activities beyond direct invasion. Research highlights hormones like pro-adrenocorticotropic hormone (pro-ACTH) and antidiuretic hormone (ADH) as key indicators.
Area of Science:
- Endocrinology and Oncology
- Tumor Biology
- Syndromic Manifestations
Context:
- Paraneoplasia encompasses tumor effects not directly caused by tumor invasion or burden.
- Research in paraneoplastic syndromes (PSN) focuses on tumor-secreted hormones.
- Understanding diverse PSN, including neurological, hematological, renal, cutaneous, and gastrointestinal, is crucial.
Purpose:
- To investigate the hormonal activities associated with paraneoplasia.
- To detail characteristic features and syndromes linked to specific tumors.
- To differentiate various paraneoplastic syndromes, particularly those affecting the nervous system, hematopoiesis, kidneys, skin, and gastrointestinal tract.
Summary:
- Paraneoplastic syndromes (PSN) are indirect effects of tumors, often involving hormone production.
- Key hormones studied include pro-adrenocorticotropic hormone (pro-ACTH) and its subgroups, antidiuretic hormone (ADH), gonadotropins, human placental lactogen (HPL), somatotropic hormone (STH), and prolactin.
- Distinctive syndromes associated with specific tumors are identified, with a focus on neurological, hematological, and organ-specific manifestations.
Impact:
- Advances understanding of the complex relationship between tumors and systemic effects.
- Provides insights into the diagnostic and prognostic value of hormonal markers in oncology.
- Facilitates the characterization and differentiation of rare paraneoplastic syndromes.